The Bioinformatics Market is projected to reach $27.98 billion by 2030, at a CAGR of 13.3% from 2023 to 2030. Bioinformatics tools are required to collect, organize, and interpret biological data. Due to the substantial increase in data volume generated by genomics research, there is a growing need for bioinformatics and computational skills to analyze, interpret, manage, and store this data effectively. Additionally, the growing amount of genomics and omics-related data generated from various research drives the demand for chemoinformatics and genome informatics.
The growth of this market is attributed to the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. However, interoperability limitations in bioinformatics platforms due to multiple data types restrain the growth of this market. Furthermore, growing clinical applications of genomic technologies and the increasing use of bioinformatics in agriculture are expected to generate growth opportunities for the players operating in this market. However, data privacy and confidentiality concerns and the shortage of skilled bioinformaticians are major challenges for market stakeholders.
The demand for biopharmaceuticals is increasing globally. Biotech companies are focused on expanding their production capacities and capabilities to meet the increasing demand and develop new biopharmaceuticals. For instance, in April 2022, FUJIFILM Diosynth Biotechnologies (U.S.) expanded its BioProcess Innovation Center in Research Triangle Park (U.S.), with plans to equip the facility with analytical instrumentation, high-throughput bioprocessing equipment, and automation technologies. Earlier, in March 2022, Amgen, Inc. (U.S.) announced the establishment of a biomanufacturing facility in North Carolina (U.S.). The facility is expected to be operational by 2025.
Bioinformatics platforms have many applications in biotechnology, including automatic genome sequencing, prediction of gene function and protein structure vaccine designing, phylogeny, gene identification, understanding gene and genome complexity, and protein structure, functionality, and folding. Biotechnology companies use bioinformatics services for genomics, proteomics, transcriptomics, and forensic sciences, among other applications.
Similarly, pharmaceutical companies use bioinformatics solutions throughout the drug discovery and development process. Identifying the drug target is a crucial step in the creation of new drugs. It requires the analysis of gene sequences, protein-protein interactions, and metabolic pathways to be performed using bioinformatics solutions. Drug targets and leads are also validated using bioinformatics tools by analyzing gene data and comparing gene expression data from untreated models and models treated with the identified lead. Moreover, biological data management solutions are used for analyzing the data generated from preclinical and clinical trials as the amount of data generated is huge, and the integration of this generated biological data is necessary for the interpretation of results.
Growing Use of Bioinformatics in Agriculture Provides Opportunities for the Players Operating in the Market
Plant genomics research is often aimed at reducing the costs associated with producing crops, improving the safety and quality of the food supply, developing superior processing abilities, and enhancing the effectiveness and efficiency of plant breeding practices. These research studies aim to improve plant resistance to biotic and abiotic stress and increase the nutritional quality of plants.
The global population is increasing rapidly; however, agricultural output is decreasing due to environmental factors. Advancements in genomics and genetics are enabling researchers to study the effects of environmental factors on the genotypic and phenotypic traits of crops and livestock. Moreover, there is a need for improved seed and crop strains that are climate, disease, biotic, and abiotic stress-resistant and provide higher yields and better nutrition, which can be fulfilled by genetically engineering seeds and plants. Genomic research on plants generates vast amounts of data. Genome informatics are used to accurately analyze and interpret this data. Additionally, biological data management solutions are also used for gene discovery, enabling researchers to develop methods to improve seed quality and incorporate added micronutrients in the plants, benefiting human health.
The Knowledge Management Software Segment to Dominate the Bioinformatics Market in 2023 With a Share of 43%
Expanding genomic datasets, growing adoption of precision medicine, growing investments in pharmaceutical R&D, and growing research in the application of genomics for several fields, including agriculture, clinical decision-making, and predictive medicine, support a large share of the segment.
The explosion of genomic, omics, and clinical data has created a need for knowledge management solutions, including biological data management tools and platforms. These solutions integrate diverse data sources, including genomic sequences, experimental results, clinical records, and references from scientific literature, resulting in an integrated and accessible format for efficient data handling, organization, and analysis.
Click here to: Get Free Sample Pages of this Report
The Genomics Segment to Account for the Largest Market Share in 2023 with a Share of 44%
The factors contributing to the segment’s large share are the growing amount of genomics data being generated, the application of genomics in chronic disease management, and the growing prevalence of chronic diseases. A substantial amount of genomic data is generated every year due to advancements in sequencing technologies and research initiatives. For instance, according to the National Human Genome Research Institute (U.S.), around 40 exabytes of storage will be required to store the genome-sequence data generated worldwide by 2025. The data leads to more information about genetics to researchers, however, it also presents several challenges in terms of data storage, processing, analysis, and interpretation. This generates a demand for genome informatics to process, analyze, and interpret large amounts of genomic data.
Healthcare Segment to Account for the Largest Market Share in 2023
This segment's large market share is attributed to the wide applications of bioinformatics in the biotechnology and pharmaceutical industry, the growth of the pharmaceutical and biotech industry, and supportive initiatives for the growth of pharmaceutical and biotech companies. The rapid expansion and initiatives such as investments and provision of grants and funds to pharmaceutical and biotechnology companies for the manufacture and R&D of biopharmaceuticals are leading in demand for bioinformatics solutions. For instance, in November 2021, Medical Research Agency (Poland) announced government funding of USD 73.3 million (PLN 300 million) for producing vaccines based on mRNA technology in Poland.
U.S. and China Among the Largest Share holding Countries
In 2023, the U.S. is expected to dominate the bioinformatics market, followed by China. The U.S. is the world's largest scientific research base, attracting the majority of global venture capital investments in the biotechnology industry. There is a high availability of government funding for various research activities, robust capital markets, and strong academic research in the country. For instance, according to the Massachusetts Biotechnology Council (MassBio), in the first six months of 2022, around USD 5 billion was invested by venture capitalists in biotech companies headquartered in Massachusetts, U.S. Owing to the high R&D expenditure, laboratories are equipped with bioinformatics to analyze and interpret the large amount of biological data generated.
Key Players
The report offers a competitive landscape based on an extensive assessment of the product portfolio offerings, geographic presence, and key strategic developments adopted by leading market players in this market in the last three to four years. The key players profiled in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.). The global bioinformatics market is fragmented in nature, and some of the global players are Thermo Fisher Scientific Inc. (U.S.), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Agilent Technologies, Inc. (U.S), F. Hoffmann–La Roche Ltd. (Switzerland), Illumina, Inc. (U.S.), and Qiagen N.V. (Netherlands). In 2022, these players collectively accounted for a share of 24%-32% of the bioinformatics market.
Report Summary:
|
Particular |
Details |
|
Page No |
198 |
|
Format |
|
|
Forecast Period |
2023-2030 |
|
Base Year |
2022 |
|
CAGR |
13.3% |
|
2030 Market Size (Value) |
$27.98 billion |
|
Segments Covered |
By Solutions & Services
By Application
By Industry
|
|
Countries Covered |
North America (U.S., Canada), Europe (Germany, France, U.K., Spain, Italy, Rest of Europe), Asia-Pacific (China, Japan, India, Rest of APAC), Latin America (Brazil, Mexico, Rest of LATAM), Middle East & Africa |
|
Key Companies |
Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.) |
Key Questions Answered in the Report:
The bioinformatics market report covers market sizes & forecasts for knowledge management software, bioinformatics platforms, and services. The study also includes the value analysis of various segments and subsegments of the bioinformatics market at the regional and country levels.
The bioinformatics market is projected to reach $27.98 billion by 2030, at a CAGR of 13.3% from 2023 to 2030.
The knowledge management software segment is estimated to account for the largest share of the bioinformatics market in 2023. Moreover, this segment is expected to record the highest CAGR during the forecast period.
Based on application, the proteomics segment is projected to gain more traction in the bioinformatics market.
The high growth of the bioinformatics market is mainly attributed to the growth of the biotech and pharmaceutical industries, initiatives supporting genomics research, and the rising need to develop novel drugs/drug molecules. Moreover, untapped markets in emerging economies, growing clinical applications of genomic technologies, and the increasing use of bioinformatics in agriculture offer market growth opportunities.
The key players operating in the bioinformatics market are Illumina, Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), F. Hoffmann-La Roche Ltd. (Switzerland), Qiagen N.V. (Netherlands), Agilent Technologies, Inc. (U.S.), Dassault Systèmes SE (France), Eurofins Genomic LLC (Germany), Revvity, Inc. (U.S.), Azenta, Inc. (U.S.), and DNAnexus, Inc. (U.S.).
China and India are expected to offer significant growth opportunities for the vendors in this market. The rising number of sequencing projects in India and the country’s participation in sequencing are enabling researchers to get a clearer picture of genes to develop new therapies, driving the market growth in India.
This report provides pre & post COVID-19 market estimates.
1. Overview
1.1. Market Definition & Scope
1.2. Market Ecosystem
1.3. Currency & Limitations
1.4. Key Stakeholders
2. Research methodology
2.1. Research Approach
2.2. Process of Data Collection and Validation
2.2.1. Secondary Research
2.2.2. Primary Research/Interviews with Key Opinion Leaders of The Industry
2.3. Market Sizing and Forecast
2.3.1. Market Size Estimation Approach
2.3.2. Growth Forecast Approach
2.3.1. Market Share Analysis
2.4. Assumptions For the Study
3. Executive Summary
4. Market Insights
4.1. Overview
4.2. Factors Affecting Market Growth
4.2.1. Market Dynamics
4.2.1.1. Drivers
4.2.1.1.1. Growth of the Biotech and Pharmaceutical Industries
4.2.1.1.2. Initiatives Supporting Genomics Research
4.2.1.1.3. Rising Need to Develop Novel Drugs/Drug Molecules
4.2.1.2. Restraints
4.2.1.2.1. Interoperability Limitations in Bioinformatics Analytical Platforms Due to Multiple Data Types
4.2.1.3. Opportunities
4.2.1.3.1. Untapped Markets in Emerging Economies
4.2.1.3.2. Growing Clinical Applications of Genomic Technologies
4.2.1.3.3. Increasing Use of Bioinformatics in Agriculture
4.2.1.4. Challenges
4.2.1.4.1. Shortage of Skilled Bioinformaticians
4.2.1.4.2. Data Privacy and Confidentiality Concerns
4.2.2. Factor Analysis
4.3. Trends
4.3.1. Integration of Artificial Intelligence (AI) and Machine Learning with Bioinformatics
4.3.1.1. AI in Genomics and Sequence Analysis
4.3.1.2. AI-driven Drug Discovery
4.3.1.3. Proteomics and AI Applications
4.3.1.4. AI for Personalized Medicine
4.4. Case Studies
4.4.1. Integration of the Client’s Multi-Disease Platform into A Single Solution
4.4.2. Provision of a Connected Analytic Solution for NGS Workflow Scaling Challenges
4.4.3. Facilitating Faster Processing and Lowering Plasmid Analysis Costs
4.5. Regulatory Analysis
5. Bioinformatics Market Assessment—by Solutions & Services
5.1. Overview
5.2. Knowledge Management Software
5.3. Bioinformatics Platforms
5.3.1. Sequence Analysis & Alignment Platforms
5.3.2. Functional & Structural Analysis Platforms
5.3.3. Other Bioinformatics Platforms
5.4. Services
5.4.1. Data Storage & Database Management Services
5.4.2. Data Analysis Services
6. Bioinformatics market assessment—by Application
6.1. Overview
6.2. Genomics
6.3. Chemoinformatics
6.4. Proteomics
6.5. Transcriptomics
6.6. Metabolomics
6.7. Other Applications
7. Bioinformatics market assessment—by Industry
7.1. Overview
7.2. Healthcare
7.3. Agriculture
7.4. Veterinary
7.5. Other Industries
8. Bioinformatics Market Assessment—by Geography
8.1. Overview
8.2. North America
8.2.1. U.S.
8.2.2. Canada
8.3. Europe
8.3.1. Germany
8.3.2. France
8.3.3. U.K.
8.3.4. Italy
8.3.5. Spain
8.3.6. Rest Of Europe
8.4. Asia-Pacific
8.4.1. China
8.4.2. India
8.4.3. Japan
8.4.4. Rest Of Asia-Pacific
8.5. Latin America
8.5.1. Brazil
8.5.2. Mexico
8.5.3. Rest of Latin America
8.6. Middle East & Africa
9. Competition Analysis
9.1. Overview
9.2. Key Growth Strategies
9.3. Competitive Benchmarking
9.4. Competitive Dashboard
9.4.1. Industry Leaders
9.4.2. Market Differentiators
9.4.3. Vanguards
9.4.4. Emerging Companies
9.5. Market Share Analysis (2022)
9.5.1. Thermo Fisher Scientific Inc. (U.S.)
9.5.2. Eurofins Genomics LLC (Germany)
9.5.3. Revvity, Inc. (U.S.)
9.5.4. Agilent Technologies, Inc. (U.S.)
9.5.5. Illumina, Inc. (U.S.)
9.5.6. F. Hoffmann–La Roche Ltd. (Switzerland)
9.5.7. Qiagen N.V. (Netherlands)
10. Company Profiles (Business Overview, Financial Overview, Product Portfolio, and Strategic Developments)
10.1. Thermo Fisher Scientific, Inc.
10.2. Eurofins Genomics LLC (Subsidiary of Eurofins Scientific SE)
10.3. Revvity, Inc. (Previously Known as Perkinelmer, Inc.)
10.4. Agilent Technologies, Inc.
10.5. Illumina, Inc.
10.6. Qiagen N.V.
10.7. Dnanexus, Inc.
10.8. Dassault Systemes SE
10.9. Azenta, Inc.
10.10. F. Hoffmann-La Roche Ltd
(Note: SWOT Analysis of the Top 5 Companies Will Be Provided)
11. Appendix
11.1. Available Customization
11.2. Related Reports
List of Tables
Table 1 Investments and Funding to Support Genomics Research
Table 2 Bioinformatics: Standards and Compliance Guidelines
Table 3 Global Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 4 Global Bioinformatics Knowledge Management Software Market, By Country/Region, 2021–2030 (USD Million)
Table 5 Global Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 6 Global Bioinformatics Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 7 Global Sequence Analysis & Alignment Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 8 Global Functional & Structural Analysis Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 9 Global Other Bioinformatics Platforms Market, By Country/Region, 2021–2030 (USD Million)
Table 10 Global Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 11 Global Bioinformatics Services Market, By Country/Region, 2021–2030 (USD Million)
Table 12 Global Data Storage & Database Management Services Market, By Country/Region, 2021–2030 (USD Million)
Table 13 Global Data Analysis Services Market, By Country/Region, 2021–2030 (USD Million)
Table 14 Global Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 15 Global Bioinformatics Market for Genomics, By Country/Region, 2021–2030 (USD Million)
Table 16 Global Bioinformatics Market for Cheminformatics, By Country/Region, 2021–2030 (USD Million)
Table 17 Number of People with Diabetes Aged 20–79, By Region, 2021 Vs. 2030 Vs. 2045 (In Thousands)
Table 18 Global Bioinformatics Market for Proteomics, By Country/Region, 2021–2030 (USD Million)
Table 19 Estimated Number of New Cancer Cases, By Type (2020 Vs. 2030)
Table 20 Global Bioinformatics Market for Transcriptomics, By Country/Region, 2021–2030 (USD Million)
Table 21 Global Bioinformatics Market for Metabolomics, By Country/Region, 2021–2030 (USD Million)
Table 22 Global Bioinformatics Market for Other Applications, By Country/Region, 2021–2030 (USD Million)
Table 23 Global Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 24 Number of Clinical Trials 2019-2021
Table 25 Global Bioinformatics Market for Healthcare, By Country/Region, 2021–2030 (USD Million)
Table 26 Global Bioinformatics Market for Agriculture Industry, By Country/Region, 2021–2030 (USD Million)
Table 27 Global Meat Consumption by Type and Region, 2020 Vs. 2026 (Thousand Tonnes)
Table 28 Global Bioinformatics Market for Veterinary, By Country/Region, 2021–2030 (USD Million)
Table 29 Global Bioinformatics Market for Other Industries, By Country/Region, 2021–2030 (USD Million)
Table 30 Global Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 31 North America: Bioinformatics Market, By Country, 2021–2030 (USD Million)
Table 32 North America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 33 North America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 34 North America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 35 North America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 36 North America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 37 U.S.: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 38 U.S.: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 39 U.S.: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 40 U.S.: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 41 U.S.: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 42 Canada: Bioinformatics Market, By Solutions & Services, 2021–2030(USD Million)
Table 43 Canada: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 44 Canada: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 45 Canada: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 46 Canada: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 47 Europe: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 48 Europe: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 49 Europe: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 50 Europe: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 51 Europe: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 52 Europe: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 53 Germany: Bioinformatics Market, By Solutions & Services, 2021–2030(USD Million)
Table 54 Germany: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 55 Germany: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 56 Germany: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 57 Germany: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 58 France: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 59 France: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 60 France: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 61 France: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 62 France: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 63 U.K. Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 64 U.K. Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 65 U.K. Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 66 U.K. Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 67 U.K. Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 68 Italy: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 69 Italy: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 70 Italy: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 71 Italy: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 72 Italy: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 73 Spain: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 74 Spain: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 75 Spain: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 76 Spain: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 77 Spain: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 78 Estimated Number of New Cancer Cases, By Country, 2020 Vs. 2030
Table 79 Rest of Europe: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 80 Rest of Europe: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 81 Rest of Europe: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 82 Rest of Europe: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 83 Rest of Europe: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 84 Asia-Pacific: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 85 Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 86 Asia-Pacific: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 87 Asia-Pacific: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 88 Asia-Pacific: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 89 Asia-Pacific: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 90 China: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 91 China: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 92 China: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 93 China: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 94 China: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 95 India: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 96 India: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 97 India: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 98 India: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 99 India: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 100 Japan: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 101 Japan: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 102 Japan: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 103 Japan: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 104 Japan: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 105 Rest of Asia-Pacific: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 106 Rest of Asia-Pacific: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 107 Rest of Asia-Pacific: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 108 Rest of Asia-Pacific: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 109 Rest of Asia-Pacific: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 110 Latin America: Bioinformatics Market, By Country/Region, 2021–2030 (USD Million)
Table 111 Latin America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 112 Latin America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 113 Latin America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 114 Latin America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 115 Latin America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 116 Brazil: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 117 Brazil: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 118 Brazil: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 119 Brazil: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 120 Brazil: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 121 Mexico: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 122 Mexico: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 123 Mexico: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 124 Mexico: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 125 Mexico: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 126 Rest of Latin America: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 127 Rest of Latin America: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 128 Rest of Latin America: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 129 Rest of Latin America: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 130 Rest of Latin America: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 131 Middle East & Africa: Bioinformatics Market, By Solutions & Services, 2021–2030 (USD Million)
Table 132 Middle East & Africa: Bioinformatics Platforms Market, By Type, 2021–2030 (USD Million)
Table 133 Middle East & Africa: Bioinformatics Services Market, By Type, 2021–2030 (USD Million)
Table 134 Middle East & Africa: Bioinformatics Market, By Application, 2021–2030 (USD Million)
Table 135 Middle East & Africa: Bioinformatics Market, By Industry, 2021–2030 (USD Million)
Table 136 Recent Developments, By Company, 2020-2023
List of Figures
Figure 1 Research Process
Figure 2 Secondary Sources Referenced for This Study
Figure 3 Primary Research Techniques
Figure 4 Key Executives Interviewed
Figure 5 Breakdown of Primary Interviews (Supply Side & Demand Side)
Figure 6 Market Sizing and Growth Forecast Approach
Figure 7 Global Bioinformatics Market, By Solution & Service, 2023 Vs. 2030 (USD Million)
Figure 8 Global Bioinformatics Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 9 Global Bioinformatics Market, By Industry, 2023 Vs. 2030 (USD Million)
Figure 10 Global Bioinformatics Market, By Geography
Figure 11 Impact Analysis of Market Dynamics
Figure 12 U.S.: Adoption of Genetically Engineered Crops, 2018 Vs. 2022
Figure 13 Pharmaceutical R&D Expenditures in The U.S., Europe, China, And Japan, 2010 Vs. 2021 (USD Billion)
Figure 14 U.S.: Number of Personalized Medicines on The Market, 2008-2020
Figure 15 Global Bioinformatics Market, By Solutions & Services, 2023 Vs. 2030 (USD Million)
Figure 16 Global Bioinformatics Market, By Application, 2023 Vs. 2030 (USD Million)
Figure 17 Applications of Metabolomics
Figure 18 Global Bioinformatics Market, By Industry, 2023 Vs. 2030 (USD Million)
Figure 19 Global Bioinformatics Market, By Geography, 2023 Vs. 2030 (USD Million)
Figure 20 North America: Bioinformatics Market Snapshot
Figure 21 U.S.: Pharmaceutical R&D Expenditure, 2014–2021 (USD Billion)
Figure 22 Europe: Pharmaceutical Industry R&D Expenditure (2000–2021)
Figure 23 Europe: Bioinformatics Market Snapshot
Figure 24 RoE: Pharmaceutical R&D Expenditure, 2020
Figure 25 Asia-Pacific: Bioinformatics Market Snapshot
Figure 26 Clinical Trial Activities in Malaysia, 2015-2025
Figure 27 Latin America: Bioinformatics Market Snapshot
Figure 28 Israel: National Committee for Transgenic Plants - Authorized Experiments, 2016-2021
Figure 29 Key Growth Strategies Adopted by Leading Players (2020–2023)
Figure 30 Bioinformatics Market: Competitive Benchmarking, By Solution & Services
Figure 31 Bioinformatics Market: Competitive Benchmarking, By Region
Figure 32 Competitive Dashboard Bioinformatics Market
Figure 33 Global Bioinformatics Market Share Analysis, By Key Players, 2022 (%)
Figure 34 Thermo Fisher Scientific, Inc.: Financial Overview (2022)
Figure 35 Eurofins Scientific SE.: Financial Overview (2022)
Figure 36 PerkinElmer, Inc.: Financial Overview (2022)
Figure 37 Agilent Technologies, Inc.: Financial Overview (2022)
Figure 38 Illumina, Inc.: Financial Overview (2022)
Figure 39 Qiagen N.V.: Financial Overview (2022)
Figure 40 Dassault Systemes SE: Financial Overview (2022)
Figure 41 Azenta, Inc.: Financial Overview (2022)
Figure 42 F. Hoffmann-La Roche Ltd.: Financial Overview (2022)
This report provides pre & post COVID-19 market estimates.
This report provides pre & post COVID-19 market estimates.
Published Date: Oct-2013
Published Date: Oct-2022
Published Date: Apr-2023
